Regional very low cerebral blood volume predicts hemorrhagic transformation better than diffusion-weighted imaging volume and thresholded apparent diffusion coefficient in acute ischemic stroke

Stroke

Volumn 41, Issue 1, 2010, Pages 82-88

  Campbell, Bruce C V ^a   Christensen, Søren ^a   Butcher, Kenneth S ^b   Gordon, Ian ^a   Parsons, Mark W ^c   Desmond, Patricia M ^a   Barber, P Alan ^d   Levi, Christopher R ^c   Bladin, Christopher F ^e   De Silva, Deidre A ^f   Donnan, Geoffrey A ^g   Davis, Stephen M ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b UNIVERSITY OF ALBERTA   (Canada)

^c UNIVERSITY OF NEWCASTLE   (Australia)

^d UNIVERSITY OF AUCKLAND   (New Zealand)

^e MONASH UNIVERSITY   (Australia)

^f NATIONAL NEUROSCIENCE INSTITUTE   (Singapore)

^g FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

Author keywords

Hemorrhage; MRI; Stroke; Thrombolytic therapy

Indexed keywords

TISSUE PLASMINOGEN ACTIVATOR;

AGED; ARTICLE; BLOOD CLOT LYSIS; BRAIN BLOOD VOLUME; BRAIN HEMATOMA; BRAIN HEMORRHAGE; BRAIN INFARCTION; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; FEMALE; HEMISPHERE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; RECANALIZATION; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY ANALYSIS;

AGED; AGED, 80 AND OVER; BLOOD VOLUME; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; CEREBROVASCULAR CIRCULATION; DIFFUSION MAGNETIC RESONANCE IMAGING; DOUBLE-BLIND METHOD; FEMALE; HUMANS; MALE; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; STROKE;

EID: 74049097509     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.109.562116     Document Type: Article

References (21)

1. Tissue plasminogen activator for acute ischemic stroke: the NINDS rt-PA study group. N Engl J Med. 1995;333:1581-1587
2. Hacke W, Kaste M, Fieschi C, von Kummer R, Davalos A, Larrue V, Bluhmki E, Davis S, Donnan G, Schneider D, Trouillas P. Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II). Lancet. 1998; 352:1245-1251.
3. Wahlgren N, Ahmed N, Davalos A, Grond M, Hacke W, Hennerici MG, Kaste M, Larrue V, Lees KR, Vanhooren G. Thrombolysis with alteplase for acute ischaemic stroke in the safe implementation of thrombolysis in stroke-monitoring study (SITS-MOST). Lancet. 2007;369:275-282
4. Intracerebral hemorrhage after intravenous t-PA therapy for ischemic stroke. The NINDS t-PA study group. Stroke. 1997;28:2109-2118.
5. Lansberg MG, Albers GW, Wijman CA. Symptomatic intracerebral hemorrhage following thrombolytic therapy for acute ischemic stroke: a review of the risk factors. Cerebrovasc Dis. 2007;24:1-10.
6. Barber PA, Demchuk AM, Zhang J, Buchan AM. Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy. ASPECTS study group. Lancet. 2000;355:1670-1674.
7. Demchuk AM, Hill MD, Barber PA, Silver B, Patel SC, Levine SR. Importance of early ischemic computed tomography changes using ASPECTS in NINDS rtPA stroke study. Stroke. 2005;36:2110-2115.
8. Hacke W, Kaste M, Fieschi C, Toni D, Lesaffre E, von Kummer R, Boysen G, Bluhmki E, Hoxter G, Mahagne MH, et al. Intravenous thrombolysis with rt-PA for acute stroke. ECASS. JAMA. 1995;274: 1017-1025.
9. Tanne D, Kasner SE, Demchuk AM, Koren-Morag N, Hanson S, Grond M, Levine SR. Markers of increased risk of intracerebral hemorrhage after intravenous rt-PA for acute ischemic stroke in clinical practice. Circulation. 2002;105:1679-1685.
10. Fiebach JB, Schellinger PD, Jansen O, Meyer M, Wilde P, Schramm P, Juttler E, Hacke W. CT and DWI in randomized order: DWI results in higher accuracy and lower interrater variability in the diagnosis of hyperacute ischemic stroke. Stroke. 2002;33:2206-2210.
11. Grotta JC, Chiu D, Lu M, Patel S, Levine SR, Haley EC, Lyden PD, Kothari R, Frankel M, Kwiatkowski T, Broderick JP, Corrigan J, Talati S, Tanne D. Agreement and variability in the interpretation of early CT changes in stroke patients qualifying for intravenous rtPA therapy. Stroke. 1999;30:1528-1533.
12. Barber PA, Darby DG, Desmond PM, Gerraty RP, Yang Q, Li T, Jolley D, Donnan GA, Tress BM, Davis SM. Identification of major ischemic change: DWI versus CT. Stroke. 1999;30:2059-2065.
13. Singer OC, Humpich MC, Fiehler J, Albers GW, Lansberg MG, Kastrup A, Rovira A, Liebeskind DS. Risk for symptomatic intracerebral hemorrhage after thrombolysis assessed by DWI MRI. Ann Neurol. 2008;63: 52-60.
14. Alsop DC, Makovetskaya E, Kumar S, Selim M, Schlaug G. Markedly reduced apparent blood volume on bolus contrast magnetic resonance imaging as a predictor of hemorrhage after thrombolytic therapy for acute ischemic stroke. Stroke. 2005;36:746-750.
15. Davis SM, Donnan GA, Parsons MW, Levi C, Butcher KS, Peeters A, Barber PA, Bladin C, De Silva DA, Chalk JB, Fink JN, Hankey G, Muir K, Gerraty R, Tress BM, Desmond PM. Effects of alteplase beyond 3 h after stroke in the echoplanar imaging thrombolytic evaluation trial (EPITHET): a placebo-controlled randomised trial. Lancet Neurol. 2008; 7:299-309.
16. Hjort N, Christensen S, Solling C, Wu O, Rohl L, Andersen G, Ostergaard L. Ischemic injury detected by DWI 11 minutes after stroke. Ann Neurol. 2005;58:462-465.
17. Hacke W, Albers G, Bogousslavsky J, Davalos A, Fischer M, Furlan A, Kaste M, Lees KR, Soehngen M, Warach S. The desmoteplase in acute ischemic stroke trial (DIAS): a phase II MRI-based 9-hour window acute stroke thrombolysis trial with intravenous desmoteplase. Stroke. 2005;36: 66-73.
18. Selim M, Fink JN, Kumar S, Caplan LR, Linfante I, Schlaug G. Predictors of hemorrhagic transformation after intravenous rt-PA: prognostic value of the initial ADC and DWI lesion volume. Stroke. 2002;33: 2047-2052.
19. Arakawa S, Wright PM, Koga M, Phan TG, Reutens DC, Donnan GA. Ischemic thresholds for gray and white matter: a diffusion and perfusion MRI study. Stroke. 2006;37:1211-1216.
20. Hacke W, Donnan G, Fieschi C, Kaste M, von Kummer R, Broderick JP, Brott T, Frankel M, Grotta JC, Albers G, Bluhmki E. Association of outcome with early stroke treatment: pooled analysis of ATLANTIS, ECASS, and NINDS rt-PA stroke trials. Lancet. 2004;363:768-774.
21. Dzialowski I, Pexman JH, Barber PA, Demchuk AM, Buchan AM, Hill MD. Asymptomatic hemorrhage after thrombolysis may not be benign: prognosis by hemorrhage type in CASES registry. Stroke. 2007;38:75-79.